A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

Autor: Yu, Elmer, Miotto, Karen, Akerele, Evaristo, Montgomery, Ann, Elkashef, Ahmed, Walsh, Robert, Montoya, Ivan, Fischman, Marian W., Collins, Joseph, McSherry, Frances, Boardman, Kathy, Davies, David K., O’Brien, Charles P., Ling, Walter, Kleber, Herbert, Herman, Barbara H.
Zdroj: In Drug and Alcohol Dependence 2008 97(1):158-168
Databáze: ScienceDirect
Externí odkaz: